HealthCare Global Enterprises Limited (NSEI: HCG)
Health Care · Health Care Providers & Services · IN
Rs589.20
-11.90% today · -15.1% 1Y
HealthCare Global Enterprises Limited (NSEI: HCG) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $908.95M and employs 6,761 people.
Over the last twelve months the share price has lost 15.1%, trading between 513.30 and 804.65.
Tweenvest scores HealthCare Global Enterprises Limited across four factors: quality 65/100, value 40/100, growth 68/100. Its strongest factor is growth.
HCG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $908.95M
- Revenue (TTM)
- $277.87M
- P/E
- —
- EPS
- 1.57
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- Rs804.65
- 52-week low
- Rs513.30
- Avg volume (3M)
- —
- Shares outstanding
- 149.30M
- Employees
- 6,761
- Next earnings
- —
About HealthCare Global Enterprises Limited
HealthCare Global Enterprises Limited, founded in 1989 and headquartered in Bengaluru, India, delivers comprehensive healthcare services with a primary focus on oncology. The company offers a full spectrum of cancer care, from diagnosis to various treatment modalities such as radiation therapy, medical oncology, and surgical procedures. Beyond its core cancer services, HCG also operates in the field of fertility and reproductive medicine under its Milann brand. This includes services like assisted reproduction, gynecological endoscopy, and fertility preservation. The enterprise further manages four multi-specialty hospitals: three branded HCG facilities located in Ahmedabad, Bhavnagar, and Rajkot in Gujarat, and one in Hubli, Karnataka, operated under a management contract. These hospitals cater to diverse medical specialities including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonary care, and critical care. Additionally, HealthCare Global provides medical diagnostic services, offering scientific testing and consultancy for the pharmaceutical and broader medical industries. As of March 31, 2021, its extensive network comprised 23 cancer centers throughout India, featuring a center of excellence in Bengaluru, alongside two independent diagnostic centers and one day-care chemotherapy unit. The company also maintains an international presence with a cancer center established in Africa.
- ISIN
- INE075I01017
- Founded
- 1989
- Listed since
- Mar 31, 2016
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ryman Healthcare LimitedNZSE: RYM | $973.25M | NZ$1.71 | +1.79% |
| Al Hammadi Holding CompanySASE: 4007 | $963.51M | SR22.61 | +0.71% |
| Regis Healthcare LimitedASX: REG | $926.60M | AU$4.39 | -0.90% |
| Summerset Group Holdings LimitedNZSE: SUM | $913.46M | NZ$6.68 | -7.22% |
| Guangxi LiuYao Group Co., LtdSHSE: 603368 | $896.50M | CN¥15.48 | +1.98% |
| Jupiter Life Line Hospitals LimitedNSEI: JLHL | $866.15M | Rs255.70 | -1.60% |
| BML, Inc.TSE: 4694 | $864.05M | ¥3,650.00 | +1.96% |
| Bangkok Chain Hospital Public Company LimitedSET: BCH | $854.80M | ฿11.50 | +2.68% |
Figures last refreshed Oct 11, 2026.